Period19 Oct 2023

Media coverage

1

Media coverage

  • TitleMount Sinai Hospital: CastleVax Receives BARDA Project NextGen Award Valued at Up to $338M to Advance Intranasal NDV-Based COVID-19 Booster Vaccine Into Phase 2b Clinical Efficacy Testing
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date19/10/23
    PersonsFlorian Krammer, Peter Palese, Adolfo Garcia-Sastre, Judith Aberg, Weina Sun, Sean Liu